Article
April 14-San Francisco-Creativity is the key to innovation and can bestbe described by the three "I"s-inspiration, insight, and intuition,according to Charles D. Kelman, MD, the foremost ophthalmic inventor ofthe 20th century.
Glaukos announces several positive clinical updates for its iDose platform
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
InflammX Therapeutics enters option agreement with Bausch + Lomb, grants right to acquire the company
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Ocugen doses first patient in phase 1 trial of OCU200 for treatment of diabetic macular edema
Inflammasome Therapeutics expands K8 trial following positive 3-month results